Founded in 1997 as a spinoff of Apex Bioscience, ApoLife provides solution for accelerated development of therapeutic antibodies through its proprietary yeast expression system. ApoLife employs Bakers yeast, which has been used for manufacturing several FDA approved therapeutic products. The company has developed platform expression technologies for the rapid and efficient screening and production of recombinant proteins and functional human antibodies. .